Iressa Study in Patients With Salivary Gland Cancer

Clinical Trial ID NCT00509002

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase II study of gefitinib in patients with advanced salivary gland cancers.	Head Neck	2015	0.83